首页> 外文期刊>Acta Oto-Laryngologica >A new combined therapy for functional organ preservation and survival in lateral oropharyngeal wall cancer
【24h】

A new combined therapy for functional organ preservation and survival in lateral oropharyngeal wall cancer

机译:一种新的联合治疗方法,用于保留口咽侧壁癌的功能器官并使其存活

获取原文
获取原文并翻译 | 示例
           

摘要

Conclusion: The outcome of this treatment was good, indicating that it is safe and effective. A favorable outcome was obtained, especially in patients with T3, N0-1, and N2a-b cancer, while outcome remained unfavorable in patients with T4a and N2c cancer. Consideration should be given to the need for intensity-modulated radiation therapy (IMRT) and maintenance therapy. Objective: To improve the survival and functional organ preservation rates in patients with lateral oropharyngeal squamous cell carcinoma. Methods: The primary site was treated conservatively by neoadjuvant chemotherapy and/or concurrent chemoradiation therapy. Chemotherapy was administered by superselective intra-arterial infusion and cervical lymph node metastasis was treated by radical neck dissection. Results: Among 71 patients, the 5- and 10-year overall survival rates were 85.1% and 63.5%, respectively; and the 5- and 10-year functional organ preservation rates were 61.0% and 51.6%, respectively. The outcomes were especially good in patients with T3 N0-1, and N2a-b cancer. All patients with N2c cancer had poor outcomes.
机译:结论:该治疗方法效果良好,表明安全有效。获得了良好的结果,尤其是在T3,N0-1和N2a-b癌症患者中,而在T4a和N2c癌症患者中结果仍然不利。应考虑对强度调制放射疗法(IMRT)和维持疗法的需求。目的:提高口咽部鳞状细胞癌患者的生存率和功能器官保存率。方法:通过新辅助化疗和/或同步放化疗保守治疗原发灶。通过超选择性动脉内输注进行化学疗法,通过根治性颈淋巴清扫术治疗颈部淋巴结转移。结果:71例患者的5年和10年总生存率分别为85.1%和63.5%。 5年和10年功能器官保存率分别为61.0%和51.6%。 T3 N0-1和N2a-b癌症患者的结局特别好。所有N2c癌症患者的预后均较差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号